We are live on ! Find out more
PALI icon

Palisade Bio
PALI

4 hedge funds and large institutions have $49.5M invested in Palisade Bio in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8,994% more capital inflows, than outflows

Capital inflows: $24.8M | Capital outflows: $273K

300% more funds holding

Funds holding: 1 → 4 (+3)

260% more call options, than puts

Call options by funds: $324K | Put options by funds: $90K

8.45% more ownership

Funds ownership: 5.25% → 13.69% (+8.4%)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
$324K
Puts
$90K
Net Calls
+$234K
Net Calls Change
+$234K

Top Buyers

Rank Fund Capital Flow
1
Putnam Investments
Putnam Investments
Massachusetts
+$12.4M
2
Fred Alger Management
Fred Alger Management
New York
+$8.28M
3
Credit Suisse
Credit Suisse
Switzerland
+$4.14M

Top Sellers

Rank Fund Capital Flow
1
Virtu KCG Holdings
Virtu KCG Holdings
New York
-$229K
2
Oppenheimer & Co
Oppenheimer & Co
New York
-$29K
3
Winslow Evans & Crocker
Winslow Evans & Crocker
Massachusetts
-$9K
4
Citigroup
Citigroup
New York
-$6K

PALI Hedge Fund Activity: Q1 2014 in Review

4 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2014, worth a combined $49.5M — up 324% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PALI positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Putnam Investments, opening a new position worth an estimated $12.4M. The largest seller was Virtu KCG Holdings, cutting an estimated $229K.

  • 4 institutional investors held Palisade Bio (PALI) as of Q1 2014, up from 1 in Q4 2013.
  • Funds reported $49.5M of Palisade Bio stock for Q1 2014, up 324% quarter-over-quarter.
  • 3 funds opened new Palisade Bio positions in Q1 2014 and 0 closed out, a net change of +3 holders.
  • The largest Palisade Bio buyer in Q1 2014 was Putnam Investments, an estimated $12.4M added.
  • The largest Palisade Bio seller in Q1 2014 was Virtu KCG Holdings, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2014.